
Published On: Dec 2021
Published On: Dec 2021
According to our latest study on “Europe Orthopedic Implant Antibacterial Coatings Surface Treatment Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type, and Material Type,” the market is projected to reach US$ 49,787.7 million by 2028 from US$ 24,906.1 million in 2021; it is expected to grow at a CAGR of 10.4% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rise in prevalence of implant-associated infections and rise in prevalence of implant-associated infections drive the market growth. However, high cost of implants with antimicrobial coating hampers the market growth.
As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering products for orthopedic implant antibacterial coatings surface treatment have their business operations in the United States and business are adversely being affected by the effects of a widespread outbreak of COVID-19. This has disrupted and restricted company’s ability to distribute products, as well as temporary closures of company’s facilities. Also, to free-up limited space for people being treated for the virus, hospitals have postponed, or cancelled. For instance, as per the British Journal of Surgery published in May 2020 stated that orthopedic procedures would be affected most, with 6.3 million operations cancelled worldwide. Cancelling elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units is also negatively affecting the growth of the orthopedic implant antibacterial coatings surface treatment market.
Based on type, the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market is bifurcated into Active Surface Finishing/Modifications (ASM), Passive Surface Finishing/Modifications (PSM), and Peri-Operative Antibacterial Local Carriers or Coatings (LCC). In 2021, the Active Surface Finishing/Modifications (ASM) segment is estimated to account for the largest market share in the Europe orthopedic implant antibacterial coatings surface treatment market. The growth of the segment is attributed to the fact that Active Surface Finishing/Modifications (ASM) involves application of pharmacologically active antibacterial agents or compounds, like antibiotics, antiseptics, metal ions, or organic molecules on the surface of orthopedic implants. Such a pharmacologically activated coatings on implant surfaces may change the implant from passive or pharmacologically inert medical device to drug loaded medical device.
DOT GmbH, Covalon Technologies Ltd., Harland Medical Systems, Inc, aap Implantate AG, BASF SE, and ARAN BIOMEDICAL are among the leading companies in the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for Orthopedic Implant Antibacterial Coatings Surface Treatment market is segmented into type and material type. Based on type, the Europe Orthopedic Implant Antibacterial Coatings Surface Treatment market is segmented into Active Surface Finishing/Modifications (ASM), Passive Surface Finishing/Modifications (PSM), and Peri-Operative Antibacterial Local Carriers or Coatings (LCC). Based on material type, the Orthopedic Implant Antibacterial Coatings Surface Treatment market is segmented into metallic coatings, and non-metallic coatings. Geographically, the Orthopedic Implant Antibacterial Coatings Surface Treatment market is segmented into Europe (Germany, UK, France, Spain, Italy, Rest of Europe).
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com